Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 1161,"Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72.",joint integrity trait,,RS:0000495,LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc,female,0 days,17,,CMO:0001453,percentage of study population developing experimental arthritis during a period of time,,,,29,%,,,MMO:0000163,in vivo visual assessment,,0.0,,,,,squalene (860 mg/ml) ,69642,squalene (860 mg/ml) 1161,"Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72.",joint integrity trait,,RS:0000495,LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc,male,0 days,6,,CMO:0001453,percentage of study population developing experimental arthritis during a period of time,,,,33,%,,,MMO:0000163,in vivo visual assessment,,0.0,,,,,squalene (860 mg/ml) ,69643,squalene (860 mg/ml) 1161,"Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72.",joint integrity trait,,RS:0000495,LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc,female,0 days,17,,CMO:0001450,post-insult time to onset of experimental arthritis,,,median,24,d,,,MMO:0000163,in vivo visual assessment,,0.0,,,,,squalene (860 mg/ml) ,69648,squalene (860 mg/ml) 1161,"Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72.",joint integrity trait,,RS:0000495,LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc,male,0 days,6,,CMO:0001450,post-insult time to onset of experimental arthritis,,,median,22,d,,,MMO:0000163,in vivo visual assessment,,0.0,,,,,squalene (860 mg/ml) ,69649,squalene (860 mg/ml)